Annual revenue:
$1.36B+$51.77M(+3.95%)Summary
- As of today (June 11, 2025), HAE annual revenue is $1.36 billion, with the most recent change of +$51.77 million (+3.95%) on March 29, 2025.
- During the last 3 years, HAE annual revenue has risen by +$367.63 million (+37.01%).
- HAE annual revenue is now at all-time high.
Performance
HAE Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly revenue:
$330.60M-$17.94M(-5.15%)Summary
- As of today (June 11, 2025), HAE quarterly revenue is $330.60 million, with the most recent change of -$17.94 million (-5.15%) on March 1, 2025.
- Over the past year, HAE quarterly revenue has dropped by -$12.69 million (-3.70%).
- HAE quarterly revenue is now -5.15% below its all-time high of $348.54 million, reached on December 28, 2024.
Performance
HAE Quarterly revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM revenue:
$1.36B-$12.69M(-0.92%)Summary
- As of today (June 11, 2025), HAE TTM revenue is $1.36 billion, with the most recent change of -$12.69 million (-0.92%) on March 1, 2025.
- Over the past year, HAE TTM revenue has increased by +$51.77 million (+3.95%).
- HAE TTM revenue is now -0.92% below its all-time high of $1.37 billion, reached on December 28, 2024.
Performance
HAE TTM revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
HAE Revenue Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +4.0% | -3.7% | +4.0% |
3 y3 years | +37.0% | +24.8% | +37.0% |
5 y5 years | +37.7% | +38.6% | +37.7% |
HAE Revenue Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +37.0% | -5.2% | +26.4% | -0.9% | +32.6% |
5 y | 5-year | at high | +56.3% | -5.2% | +69.0% | -0.9% | +56.3% |
alltime | all time | at high | +765.1% | -5.2% | +741.2% | -0.9% | +3362.7% |
HAE Revenue History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2025 | $1.36B(+4.0%) | - | - |
Mar 2025 | - | $330.60M(-5.1%) | $1.36B(-0.9%) |
Dec 2024 | - | $348.54M(+0.9%) | $1.37B(+0.9%) |
Sep 2024 | - | $345.51M(+2.8%) | $1.36B(+2.0%) |
Jun 2024 | - | $336.17M(-2.1%) | $1.33B(+1.9%) |
Mar 2024 | $1.31B(+12.0%) | - | - |
Mar 2024 | - | $343.29M(+2.1%) | $1.31B(+3.1%) |
Dec 2023 | - | $336.25M(+5.7%) | $1.27B(+2.5%) |
Sep 2023 | - | $318.18M(+2.2%) | $1.24B(+1.7%) |
Jun 2023 | - | $311.33M(+2.3%) | $1.22B(+4.3%) |
Mar 2023 | $1.17B(+17.7%) | $304.42M(-0.3%) | $1.17B(+3.5%) |
Dec 2022 | - | $305.30M(+2.6%) | $1.13B(+4.2%) |
Sep 2022 | - | $297.49M(+13.8%) | $1.08B(+5.6%) |
Jun 2022 | - | $261.46M(-1.3%) | $1.03B(+3.3%) |
Mar 2022 | $993.20M(+14.1%) | $265.00M(+2.0%) | $993.20M(+4.2%) |
Dec 2021 | - | $259.77M(+8.3%) | $953.22M(+2.1%) |
Sep 2021 | - | $239.90M(+5.0%) | $933.83M(+3.4%) |
Jun 2021 | - | $228.53M(+1.6%) | $903.41M(+3.8%) |
Mar 2021 | $870.46M(-11.9%) | $225.03M(-6.4%) | $870.46M(-1.5%) |
Dec 2020 | - | $240.37M(+14.7%) | $883.93M(-2.1%) |
Sep 2020 | - | $209.49M(+7.1%) | $902.52M(-4.6%) |
Jun 2020 | - | $195.58M(-18.0%) | $945.61M(-4.3%) |
Mar 2020 | $988.48M(+2.2%) | $238.49M(-7.9%) | $988.48M(-1.1%) |
Dec 2019 | - | $258.97M(+2.5%) | $999.28M(+1.2%) |
Sep 2019 | - | $252.57M(+5.9%) | $987.67M(+1.1%) |
Jun 2019 | - | $238.45M(-4.3%) | $976.68M(+0.9%) |
Mar 2019 | $967.58M(+7.0%) | $249.29M(+0.8%) | $967.58M(+1.7%) |
Dec 2018 | - | $247.36M(+2.4%) | $951.84M(+1.4%) |
Sep 2018 | - | $241.58M(+5.3%) | $938.52M(+1.8%) |
Jun 2018 | - | $229.35M(-1.8%) | $922.32M(+2.0%) |
Mar 2018 | $903.92M(+2.0%) | $233.55M(-0.2%) | $903.92M(+0.6%) |
Dec 2017 | - | $234.04M(+3.8%) | $898.44M(+0.7%) |
Sep 2017 | - | $225.38M(+6.8%) | $892.24M(+0.6%) |
Jun 2017 | - | $210.95M(-7.5%) | $887.11M(+0.1%) |
Mar 2017 | $886.12M(-2.5%) | $228.07M(+0.1%) | $886.12M(-1.6%) |
Dec 2016 | - | $227.84M(+3.4%) | $900.39M(-0.6%) |
Sep 2016 | - | $220.25M(+4.9%) | $905.93M(+0.1%) |
Jun 2016 | - | $209.96M(-13.4%) | $905.38M(-0.4%) |
Mar 2016 | $908.83M(-0.2%) | $242.34M(+3.8%) | $908.83M(+1.8%) |
Dec 2015 | - | $233.38M(+6.2%) | $892.97M(+0.2%) |
Sep 2015 | - | $219.69M(+2.9%) | $891.41M(-0.9%) |
Jun 2015 | - | $213.41M(-5.8%) | $899.30M(-1.2%) |
Mar 2015 | $910.37M(-3.0%) | $226.48M(-2.3%) | $910.37M(-1.6%) |
Dec 2014 | - | $231.83M(+1.9%) | $924.99M(-1.1%) |
Sep 2014 | - | $227.58M(+1.4%) | $935.28M(-0.9%) |
Jun 2014 | - | $224.49M(-6.9%) | $943.45M(+0.5%) |
Mar 2014 | $938.51M(+5.2%) | $241.09M(-0.4%) | $938.51M(-0.9%) |
Dec 2013 | - | $242.12M(+2.7%) | $947.36M(-0.6%) |
Sep 2013 | - | $235.75M(+7.4%) | $952.63M(+1.9%) |
Jun 2013 | - | $219.54M(-12.2%) | $935.06M(+4.8%) |
Mar 2013 | $891.99M(+22.6%) | $249.94M(+1.0%) | $891.99M(+7.6%) |
Dec 2012 | - | $247.40M(+13.4%) | $828.72M(+7.3%) |
Sep 2012 | - | $218.18M(+23.6%) | $772.48M(+5.3%) |
Jun 2012 | - | $176.47M(-5.5%) | $733.75M(+0.8%) |
Mar 2012 | $727.84M(+7.6%) | $186.67M(-2.3%) | $727.84M(+2.3%) |
Dec 2011 | - | $191.16M(+6.5%) | $711.21M(+2.1%) |
Sep 2011 | - | $179.44M(+5.2%) | $696.84M(+1.8%) |
Jun 2011 | - | $170.57M(+0.3%) | $684.22M(+1.1%) |
Mar 2011 | $676.69M(+4.8%) | $170.03M(-3.8%) | $676.69M(+0.1%) |
Dec 2010 | - | $176.79M(+6.0%) | $675.76M(+1.7%) |
Sep 2010 | - | $166.83M(+2.3%) | $664.14M(+1.5%) |
Jun 2010 | - | $163.04M(-3.6%) | $654.38M(+1.4%) |
Mar 2010 | $645.43M(+8.0%) | $169.10M(+2.4%) | $645.43M(+2.7%) |
Dec 2009 | - | $165.17M(+5.2%) | $628.72M(+1.6%) |
Sep 2009 | - | $157.07M(+1.9%) | $619.00M(+1.8%) |
Jun 2009 | - | $154.09M(+1.1%) | $607.85M(+1.7%) |
Mar 2009 | $597.88M(+15.8%) | $152.40M(-2.0%) | $597.88M(+2.3%) |
Dec 2008 | - | $155.45M(+6.5%) | $584.22M(+3.7%) |
Sep 2008 | - | $145.92M(+1.3%) | $563.36M(+4.6%) |
Jun 2008 | - | $144.12M(+3.9%) | $538.62M(+4.3%) |
Mar 2008 | $516.44M | $138.74M(+3.1%) | $516.44M(+4.4%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2007 | - | $134.59M(+11.1%) | $494.62M(+4.4%) |
Sep 2007 | - | $121.18M(-0.6%) | $473.56M(+2.8%) |
Jun 2007 | - | $121.94M(+4.3%) | $460.87M(+2.5%) |
Mar 2007 | $449.61M(+7.1%) | $116.92M(+3.0%) | $449.61M(+1.5%) |
Dec 2006 | - | $113.53M(+4.6%) | $443.08M(+1.8%) |
Sep 2006 | - | $108.49M(-2.0%) | $435.23M(+1.9%) |
Jun 2006 | - | $110.67M(+0.3%) | $427.23M(+1.8%) |
Mar 2006 | $419.73M(+9.4%) | $110.39M(+4.5%) | $419.73M(+2.5%) |
Dec 2005 | - | $105.68M(+5.2%) | $409.31M(+1.9%) |
Sep 2005 | - | $100.49M(-2.6%) | $401.73M(+2.4%) |
Jun 2005 | - | $103.17M(+3.2%) | $392.17M(+2.2%) |
Mar 2005 | $383.60M(+5.3%) | $99.97M(+1.9%) | $383.60M(+0.6%) |
Dec 2004 | - | $98.10M(+7.9%) | $381.34M(+2.0%) |
Sep 2004 | - | $90.92M(-3.9%) | $373.98M(+0.9%) |
Jun 2004 | - | $94.60M(-3.2%) | $370.55M(+1.7%) |
Mar 2004 | $364.23M(+8.1%) | $97.72M(+7.7%) | $364.23M(+4.8%) |
Dec 2003 | - | $90.74M(+3.7%) | $347.39M(+1.1%) |
Sep 2003 | - | $87.49M(-0.9%) | $343.77M(+0.1%) |
Jun 2003 | - | $88.28M(+9.2%) | $343.30M(+1.9%) |
Mar 2003 | $336.96M(+5.3%) | $80.88M(-7.2%) | $336.96M(+0.5%) |
Dec 2002 | - | $87.11M(+0.1%) | $335.13M(+0.8%) |
Sep 2002 | - | $87.03M(+6.2%) | $332.42M(+1.9%) |
Jun 2002 | - | $81.94M(+3.6%) | $326.10M(+1.9%) |
Mar 2002 | $319.97M(+8.9%) | $79.05M(-6.3%) | $319.97M(+0.4%) |
Dec 2001 | - | $84.41M(+4.6%) | $318.61M(+2.7%) |
Sep 2001 | - | $80.70M(+6.5%) | $310.10M(+3.2%) |
Jun 2001 | - | $75.80M(-2.4%) | $300.34M(+1.9%) |
Mar 2001 | $293.86M(+4.7%) | $77.70M(+2.4%) | $294.81M(+1.8%) |
Dec 2000 | - | $75.90M(+7.0%) | $289.62M(+1.8%) |
Sep 2000 | - | $70.94M(+1.0%) | $284.52M(+1.0%) |
Jun 2000 | - | $70.27M(-3.1%) | $281.78M(+0.4%) |
Mar 2000 | $280.61M(-1.4%) | $72.51M(+2.4%) | $280.61M(-1.5%) |
Dec 1999 | - | $70.80M(+3.8%) | $284.91M(+1.0%) |
Sep 1999 | - | $68.20M(-1.3%) | $282.11M(+0.1%) |
Jun 1999 | - | $69.10M(-10.0%) | $281.71M(-1.0%) |
Mar 1999 | $284.51M(-0.5%) | $76.81M(+13.0%) | $284.61M(+5.0%) |
Dec 1998 | - | $68.00M(+0.3%) | $271.10M(-0.9%) |
Sep 1998 | - | $67.80M(-5.8%) | $273.60M(-1.7%) |
Jun 1998 | - | $72.00M(+13.7%) | $278.30M(-3.6%) |
Mar 1998 | $285.80M(-5.7%) | $63.30M(-10.2%) | $288.60M(-4.4%) |
Dec 1997 | - | $70.50M(-2.8%) | $301.80M(-2.0%) |
Sep 1997 | - | $72.50M(-11.9%) | $307.90M(-0.6%) |
Jun 1997 | - | $82.30M(+7.6%) | $309.80M(+2.2%) |
Mar 1997 | $303.00M(+8.9%) | $76.50M(-0.1%) | $303.00M(+2.1%) |
Dec 1996 | - | $76.60M(+3.0%) | $296.90M(+2.3%) |
Sep 1996 | - | $74.40M(-1.5%) | $290.20M(+1.9%) |
Jun 1996 | - | $75.50M(+7.2%) | $284.90M(+2.4%) |
Mar 1996 | $278.20M(+6.0%) | $70.40M(+0.7%) | $278.20M(+0.8%) |
Dec 1995 | - | $69.90M(+1.2%) | $276.00M(+1.6%) |
Sep 1995 | - | $69.10M(+0.4%) | $271.70M(+1.4%) |
Jun 1995 | - | $68.80M(+0.9%) | $267.90M(+2.1%) |
Mar 1995 | $262.40M(+5.6%) | $68.20M(+4.0%) | $262.40M(+1.6%) |
Dec 1994 | - | $65.60M(+0.5%) | $258.30M(+0.9%) |
Sep 1994 | - | $65.30M(+3.2%) | $255.90M(+1.1%) |
Jun 1994 | - | $63.30M(-1.2%) | $253.20M(+1.9%) |
Mar 1994 | $248.40M(+14.8%) | $64.10M(+1.4%) | $248.40M(+2.7%) |
Dec 1993 | - | $63.20M(+1.0%) | $241.80M(+2.6%) |
Sep 1993 | - | $62.60M(+7.0%) | $235.70M(+4.2%) |
Jun 1993 | - | $58.50M(+1.7%) | $226.20M(+4.6%) |
Mar 1993 | $216.30M(+22.6%) | $57.50M(+0.7%) | $216.30M(+4.6%) |
Dec 1992 | - | $57.10M(+7.5%) | $206.80M(+6.2%) |
Sep 1992 | - | $53.10M(+9.3%) | $194.70M(+5.4%) |
Jun 1992 | - | $48.60M(+1.3%) | $184.80M(+4.8%) |
Mar 1992 | $176.40M(+12.1%) | $48.00M(+6.7%) | $176.30M(+5.1%) |
Dec 1991 | - | $45.00M(+4.2%) | $167.70M(+3.5%) |
Sep 1991 | - | $43.20M(+7.7%) | $162.00M(+2.5%) |
Jun 1991 | - | $40.10M(+1.8%) | $158.10M(+0.5%) |
Mar 1991 | $157.30M | $39.40M(+0.3%) | $157.30M(+33.4%) |
Dec 1990 | - | $39.30M(0.0%) | $117.90M(+50.0%) |
Sep 1990 | - | $39.30M(0.0%) | $78.60M(+100.0%) |
Jun 1990 | - | $39.30M | $39.30M |
FAQ
- What is Haemonetics annual revenue?
- What is the all time high annual revenue for Haemonetics?
- What is Haemonetics annual revenue year-on-year change?
- What is Haemonetics quarterly revenue?
- What is the all time high quarterly revenue for Haemonetics?
- What is Haemonetics quarterly revenue year-on-year change?
- What is Haemonetics TTM revenue?
- What is the all time high TTM revenue for Haemonetics?
- What is Haemonetics TTM revenue year-on-year change?
What is Haemonetics annual revenue?
The current annual revenue of HAE is $1.36B
What is the all time high annual revenue for Haemonetics?
Haemonetics all-time high annual revenue is $1.36B
What is Haemonetics annual revenue year-on-year change?
Over the past year, HAE annual revenue has changed by +$51.77M (+3.95%)
What is Haemonetics quarterly revenue?
The current quarterly revenue of HAE is $330.60M
What is the all time high quarterly revenue for Haemonetics?
Haemonetics all-time high quarterly revenue is $348.54M
What is Haemonetics quarterly revenue year-on-year change?
Over the past year, HAE quarterly revenue has changed by -$12.69M (-3.70%)
What is Haemonetics TTM revenue?
The current TTM revenue of HAE is $1.36B
What is the all time high TTM revenue for Haemonetics?
Haemonetics all-time high TTM revenue is $1.37B
What is Haemonetics TTM revenue year-on-year change?
Over the past year, HAE TTM revenue has changed by +$51.77M (+3.95%)